Context Therapeutics Inc.

US$0.19As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:CNTXHealthcare
Country USA
PE (Fwd) •••
TSR 5Y CAGR (49.13%)
Div yield —
ROE (76.14%)
Biotechnology
Beta (5Y) 1.80
PE TTM —
TSR TTM (82.25%)
Mkt cap US$17.78M
ROIC (50.28%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$0.188
(2.94%)
84.09%
Hold 2|3|4|8|7
4Q25
1Q26
2Q26
3Q26
Earnings per share$
—
—
—
—
18.34%
26.68%
21.14%
14.27%
Revenue$M
1.964
2.059
2.104
2.045
6.98%
14.55%
11.81%
9.29%
Peers (US$17.78M)
Cap (US$)
PE
17.91M
—
Capital
TTM
5Y
10Y
Leveragex
0.520
1.671
1.101
EBIT/Intx
0.536
0.719
0.579
Own earn%
(262.26)
(62.90)
(53.72)
Sh yield%
44.60
18.77
18.74
Owners
Insiders/Inst%
8.15
38.72
Short interest%
3.58
SBC / revenue%
3.19
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
18
Op margin range%
2–9
$1 testx
0.0
Incr. ROIC%
7